India
· Delayed Price · Currency is INR Mono Pharmacare Statistics
Total Valuation
Mono Pharmacare has a market cap or net worth of INR 441.71 million. The enterprise value is 927.78 million.
| Market Cap | 441.71M |
| Enterprise Value | 927.78M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Mono Pharmacare has 17.67 million shares outstanding. The number of shares has increased by 80.03% in one year.
| Current Share Class | 17.67M |
| Shares Outstanding | 17.67M |
| Shares Change (YoY) | +80.03% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 68.79% |
| Owned by Institutions (%) | n/a |
| Float | 5.51M |
Valuation Ratios
The trailing PE ratio is 15.47.
| PE Ratio | 15.47 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 1.45 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.33 |
| EV / Sales | 0.65 |
| EV / EBITDA | 12.83 |
| EV / EBIT | 12.94 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 1.60.
| Current Ratio | 2.09 |
| Quick Ratio | 0.98 |
| Debt / Equity | 1.60 |
| Debt / EBITDA | 6.73 |
| Debt / FCF | n/a |
| Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is 9.96% and return on invested capital (ROIC) is 6.19%.
| Return on Equity (ROE) | 9.96% |
| Return on Assets (ROA) | 5.13% |
| Return on Invested Capital (ROIC) | 6.19% |
| Return on Capital Employed (ROCE) | 13.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.64 |
| Inventory Turnover | 3.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.66% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -42.66% |
| 50-Day Moving Average | 24.84 |
| 200-Day Moving Average | 35.07 |
| Relative Strength Index (RSI) | 52.32 |
| Average Volume (20 Days) | 23,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mono Pharmacare had revenue of INR 1.43 billion and earned 28.70 million in profits. Earnings per share was 1.62.
| Revenue | 1.43B |
| Gross Profit | 133.42M |
| Operating Income | 71.69M |
| Pretax Income | 40.35M |
| Net Income | 28.70M |
| EBITDA | 72.33M |
| EBIT | 71.69M |
| Earnings Per Share (EPS) | 1.62 |
Balance Sheet
The company has 1.31 million in cash and 487.11 million in debt, giving a net cash position of -485.80 million or -27.50 per share.
| Cash & Cash Equivalents | 1.31M |
| Total Debt | 487.11M |
| Net Cash | -485.80M |
| Net Cash Per Share | -27.50 |
| Equity (Book Value) | 304.29M |
| Book Value Per Share | 17.24 |
| Working Capital | 513.66M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 9.32%, with operating and profit margins of 5.01% and 2.01%.
| Gross Margin | 9.32% |
| Operating Margin | 5.01% |
| Pretax Margin | 2.82% |
| Profit Margin | 2.01% |
| EBITDA Margin | 5.06% |
| EBIT Margin | 5.01% |
| FCF Margin | n/a |
Dividends & Yields
Mono Pharmacare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.03% |
| Shareholder Yield | -80.03% |
| Earnings Yield | 6.50% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |